1-8 of 8
Mark Crowther
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations

Debbie Jiang, Wendy Lim, Mark Crowther, David Garcia
Journal: Blood Advances
Blood Adv (2021) 5 (20): 3931–3936.
https://doi.org/10.1182/bloodadvances.2021005205
Published: 2021
Journal Articles

Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study

Clinical Trials & Observations
Jason B. Hill, David Garcia, Mark Crowther, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5373–5377.
https://doi.org/10.1182/bloodadvances.2020003083
Published: 2020
Journal Articles

Iron deficiency following bariatric surgery: a retrospective cohort study

Clinical Trials & Observations
Zachary Gowanlock, Anastasiya Lezhanska, Maeve Conroy, Mark Crowther, Maria Tiboni, Lawrence Mbuagbaw, Deborah M. Siegal
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3639–3647.
https://doi.org/10.1182/bloodadvances.2020001880
Published: 2020
Includes: Supplemental data
Journal Articles

Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)

Clinical Trials & Observations
Reza Mirza, Robby Nieuwlaat, Juan J. López-Núñez, Raquel Barba, Arnav Agarwal, Carme Font, Maurizio Ciammaichella, Elvira Grandone, Rick Ikesaka, Mark Crowther, Manuel Monreal, the RIETE Investigators
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2460–2467.
https://doi.org/10.1182/bloodadvances.2019001373
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers

Clinical Trials & Observations
Genmin Lu, Pamela B. Conley, Janet M. Leeds, Mark J. Karbarz, Gallia G. Levy, Vandana S. Mathur, Janice Castillo, Mark Crowther, John T. Curnutte
Journal: Blood Advances
Blood Adv (2020) 4 (4): 728–739.
https://doi.org/10.1182/bloodadvances.2019000885
Published: 2020
Includes: Supplemental data
Journal Articles

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia

Clinical Trials & Observations
Allyson M. Pishko, Sara Fardin, Daniel S. Lefler, Koosha Paydary, Rolando Vega, Gowthami M. Arepally, Mark Crowther, Lawrence Rice, Douglas B. Cines, Adam Cuker
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3155–3162.
https://doi.org/10.1182/bloodadvances.2018023077
Published: 2018
Includes: Supplemental data
Journal Articles

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa

Deborah Siegal, Genmin Lu, Janet M. Leeds, Mark Karbarz, Janice Castillo, Vandana Mathur, Athiwat Hutchaleelaha, Uma Sinha, Michael Kitt, Matt McClure, Stanley J. Hollenbach, John T. Curnutte, Pamela B. Conley, Mark Crowther
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1827–1838.
https://doi.org/10.1182/bloodadvances.2017007112
Published: 2017
Includes: Supplemental data
Journal Articles

The direct oral anticoagulants: can we finally stop using rat poison?

Mark Crowther
Journal: Blood Advances
Blood Adv (2017) 1 (14): 980.
https://doi.org/10.1182/bloodadvances.2017002907
Published: 2017
Includes: Supplemental data